Literature DB >> 22872639

Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome.

Wen-cai Zhang1, Jun Wang, Yan-wen Shu, Ting-ting Tang, Zheng-feng Zhu, Ni Xia, Shao-fang Nie, Juan Liu, Su-feng Zhou, Jing-jing Li, Hong Xiao, Jing Yuan, Meng-yang Liao, Long-xian Cheng, Yu-hua Liao, Xiang Cheng.   

Abstract

Regulatory T (Treg) cells play a protective role against the development of atherosclerosis. Previous studies have revealed Treg cell defects in patients with non-ST elevation acute coronary syndrome (NSTACS), but the mechanisms underlying these defects remain unclear. In this study, we found that the numbers of peripheral blood CD4(+)CD25(+)CD127(low) Treg cells and CD4(+)CD25(+)CD127(low)CD45RA(+)CD45RO(-) naive Treg cells were lower in the NSTACS patients than in the chronic stable angina (CSA) and the chest pain syndrome (CPS) patients. However, the number of CD4(+)CD25(+)CD127(low)CD45RA(-)CD45RO(+) memory Treg cells was comparable in all of the groups. The frequency of CD4(+)CD25(+)CD127(low)CD45RO(-)CD45RA(+)CD31(+) recent thymic emigrant Treg cells and the T cell receptor excision circle content of purified Treg cells were lower in the NSTACS patients than in the CSA patients and the CPS controls. The spontaneous apoptosis of Treg cells (defined as CD4(+)CD25(+)CD127(low)annexin V(+)7-AAD(-)) was increased in the NSTACS patients compared with the CSA and CPS groups. Furthermore, oxidized LDL could induce Treg cell apoptosis, and the oxidized LDL levels were significantly higher in the NSTACS patients than in the CSA and CPS groups. In accordance with the altered Treg cell levels, the concentration of TNF-α was increased in the NSTACS patients, resulting in a decreased IL-10/TNF-α ratio. These findings indicate that the impaired thymic output of Treg cells and their enhanced susceptibility to apoptosis in the periphery were responsible for Treg cell defects observed in the NSTACS patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872639      PMCID: PMC3464524          DOI: 10.1074/jbc.M112.382978

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation.

Authors:  M D Hazenberg; M C Verschuren; D Hamann; F Miedema; J J van Dongen
Journal:  J Mol Med (Berl)       Date:  2001-11       Impact factor: 4.599

Review 2.  The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery.

Authors:  Arne N Akbar; Milica Vukmanovic-Stejic; Leonie S Taams; Derek C Macallan
Journal:  Nat Rev Immunol       Date:  2007-03       Impact factor: 53.106

3.  Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.

Authors:  Adi Mor; David Planer; Galia Luboshits; Arnon Afek; Shula Metzger; Tova Chajek-Shaul; Gad Keren; Jacob George
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

Review 4.  Mechanisms of T regulatory cell function.

Authors:  Nadir Askenasy; Ayelet Kaminitz; Shai Yarkoni
Journal:  Autoimmun Rev       Date:  2008-03-24       Impact factor: 9.754

5.  Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes.

Authors:  S Ehara; M Ueda; T Naruko; K Haze; A Itoh; M Otsuka; R Komatsu; T Matsuo; H Itabe; T Takano; Y Tsukamoto; M Yoshiyama; K Takeuchi; J Yoshikawa; A E Becker
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

6.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  Multiple immuno-regulatory defects in type-1 diabetes.

Authors:  Anjli Kukreja; Giulia Cost; John Marker; Chenhui Zhang; Zhong Sun; Karen Lin-Su; Svetlana Ten; Maureen Sanz; Mark Exley; Brian Wilson; Steven Porcelli; Noel Maclaren
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina.

Authors:  D A Smith; S D Irving; J Sheldon; D Cole; J C Kaski
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

9.  Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases.

Authors:  Shoichi Ehara; Makiko Ueda; Takahiko Naruko; Kazuo Haze; Toshihiko Matsuo; Masayuki Ogami; Yoshihiro Ikura; Hiroyuki Itabe; Ryushi Komatsu; Minoru Yoshiyama; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  J Diabetes Complications       Date:  2002 Jan-Feb       Impact factor: 2.852

Review 10.  Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.

Authors:  Harald Loppnow; Karl Werdan; Michael Buerke
Journal:  Innate Immun       Date:  2008-04       Impact factor: 2.680

View more
  20 in total

Review 1.  Regulatory T cells as a new therapeutic target for atherosclerosis.

Authors:  Han-Xiao Ou; Bing-Bing Guo; Qi Liu; Yu-Kun Li; Zhen Yang; Wen-Jie Feng; Zhong-Cheng Mo
Journal:  Acta Pharmacol Sin       Date:  2018-01-11       Impact factor: 6.150

Review 2.  Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications.

Authors:  Davide Flego; Giovanna Liuzzo; Cornelia M Weyand; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2016-11-08       Impact factor: 24.094

Review 3.  Treating atherosclerosis with regulatory T cells.

Authors:  Amanda C Foks; Andrew H Lichtman; Johan Kuiper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-20       Impact factor: 8.311

Review 4.  The influence of innate and adaptive immune responses on atherosclerosis.

Authors:  Joseph L Witztum; Andrew H Lichtman
Journal:  Annu Rev Pathol       Date:  2013-08-07       Impact factor: 23.472

Review 5.  Regulatory T cells in cardiovascular diseases.

Authors:  Xiao Meng; Jianmin Yang; Mei Dong; Kai Zhang; Eric Tu; Qi Gao; Wanjun Chen; Cheng Zhang; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2015-11-03       Impact factor: 32.419

6.  Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis.

Authors:  Nels C Olson; Margaret F Doyle; Nancy Swords Jenny; Sally A Huber; Bruce M Psaty; Richard A Kronmal; Russell P Tracy
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

7.  Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes.

Authors:  Ying-zhong Lin; Shan-he Lu; Zheng-de Lu; Ying Huang; Ying Shi; Ling Liu; Xiao-yan Wang; Qing-wei Ji
Journal:  Mediators Inflamm       Date:  2013-12-10       Impact factor: 4.711

Review 8.  Targeting T cells to treat atherosclerosis: odyssey from bench to bedside.

Authors:  Jessica Bullenkamp; Sip Dinkla; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2016-01-24

9.  Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.

Authors:  Monika Sharma; Martin P Schlegel; Milessa S Afonso; Emily J Brown; Karishma Rahman; Ada Weinstock; Brian E Sansbury; Emma M Corr; Coen van Solingen; Graeme J Koelwyn; Lianne C Shanley; Lauren Beckett; Daniel Peled; Juan J Lafaille; Matthew Spite; P'ng Loke; Edward A Fisher; Kathryn J Moore
Journal:  Circ Res       Date:  2020-04-27       Impact factor: 17.367

10.  Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study.

Authors:  Zheng-Feng Zhu; Kai Meng; Yu-Cheng Zhong; Liang Qi; Xiao-Bo Mao; Kun-Wu Yu; Wei Zhang; Peng-Fei Zhu; Ze-Peng Ren; Bang-Wei Wu; Qin-Wei Ji; Xiang Wang; Qiu-Tang Zeng
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.